New drug combo may slash stroke risk in high-risk patients

NCT ID NCT06591338

Recruiting now Disease control Sponsor: Kafrelsheikh University Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated Apr 28, 2026 · Updated 22 times

Summary

This study compares two anti-clotting drug combinations—aspirin plus ticagrelor versus aspirin plus clopidogrel—in 900 people who recently had a minor stroke or transient ischemic attack (TIA) caused by a large artery blockage. The goal is to see which combo better prevents another stroke within three months while keeping bleeding risks low. Participants receive treatment within 24 hours of their first event and are followed for 90 days.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Kafr Elsheikh University Hospital
RECRUITING

Kafr ash Shaykh, 33511, Egypt

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ISCHEMIC STROKE